Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression.
Mandel I, Haves Ziv D, Goldshtein I, Peretz T, Alishekevitz D, Fridman Dror A, Hakim M, Hashmueli S, Friedman I, Sapir Y, Greco R, Qu H, Nestle F, Wiederschain D, Pao L, Sharma S, Ben Moshe T. Mandel I, et al. Among authors: fridman dror a. J Immunother Cancer. 2022 Sep;10(9):e004859. doi: 10.1136/jitc-2022-004859. J Immunother Cancer. 2022. PMID: 36096532 Free PMC article.
Donor cell leukemia: reappearance of gene mutations in donor cells - more than an incidental phenomenon?
Shahar Gabay T, Chapal-Ilani N, Moskovitz Y, Biezuner T, Oron B, Brilon Y, Fridman-Dror A, Sabah R, Balicer R, Tanay A, Mendelson-Cohen N, Dann EJ, Fineman R, Kaushansky N, Yehudai-Reshef S, Zuckerman T, Shlush LI. Shahar Gabay T, et al. Among authors: fridman dror a. Haematologica. 2020 Dec 1;105(12):2861-2863. doi: 10.3324/haematol.2019.242347. Haematologica. 2020. PMID: 33256388 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 32381578